Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 707

1.

Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.

Fadare O, Dadmanesh F, Alvarado-Cabrero I, Snyder R, Stephen Mitchell J, Tot T, Wang SA, Ghofrani M, Eusebi V, Martel M, Tavassoli FA.

Am J Surg Pathol. 2006 Nov;30(11):1445-53.

PMID:
17063087
2.

Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias.

Bratthauer GL, Moinfar F, Stamatakos MD, Mezzetti TP, Shekitka KM, Man YG, Tavassoli FA.

Hum Pathol. 2002 Jun;33(6):620-7.

PMID:
12152161
3.
4.
5.

Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast.

Bratthauer GL, Tavassoli FA.

Virchows Arch. 2004 Apr;444(4):340-4.

PMID:
14986131
6.

Florid lobular intraepithelial neoplasia with signet ring cells, central necrosis and calcifications: a clinicopathological and immunohistochemical analysis of ten cases associated with invasive lobular carcinoma.

Alvarado-Cabrero I, Picón Coronel G, Valencia Cedillo R, Canedo N, Tavassoli FA.

Arch Med Res. 2010 Aug;41(6):436-41. doi: 10.1016/j.arcmed.2010.08.010.

PMID:
21044747
7.

Caveolin-1 expression in human breast lobular cancer progression.

Perrone G, Altomare V, Zagami M, Morini S, Petitti T, Battista C, Muda AO, Rabitti C.

Mod Pathol. 2009 Jan;22(1):71-8. doi: 10.1038/modpathol.2008.154.

9.

Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.

Chivukula M, Haynik DM, Brufsky A, Carter G, Dabbs DJ.

Am J Surg Pathol. 2008 Nov;32(11):1721-6. doi: 10.1097/PAS.0b013e31817dc3a6.

PMID:
18769331
10.

Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity.

Reis-Filho JS, Simpson PT, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Valgeirsson H, Lambros M, Ashworth A, Palacios J, Schmitt F, Lakhani SR.

J Pathol. 2005 Sep;207(1):1-13.

PMID:
15957152
11.

The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?

Fadare O, Wang SA, Hileeto D.

Hum Pathol. 2008 Mar;39(3):331-6. doi: 10.1016/j.humpath.2007.07.014.

PMID:
18261623
13.

Positioning of necrotic lobular intraepithelial neoplasias (LIN, grade 3) within the sequence of breast carcinoma progression.

Boldt V, Stacher E, Halbwedl I, Popper H, Hultschig C, Moinfar F, Ullmann R, Tavassoli FA.

Genes Chromosomes Cancer. 2010 May;49(5):463-70. doi: 10.1002/gcc.20756.

PMID:
20155841
14.

Tubulolobular carcinoma of the breast: an analysis of 27 cases of a tumor with a hybrid morphology and immunoprofile.

Wheeler DT, Tai LH, Bratthauer GL, Waldner DL, Tavassoli FA.

Am J Surg Pathol. 2004 Dec;28(12):1587-93.

PMID:
15577677
15.
17.

Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?

Middleton LP, Grant S, Stephens T, Stelling CB, Sneige N, Sahin AA.

Mod Pathol. 2003 Feb;16(2):120-9.

18.

Lobular neoplasia displaying central necrosis: a potential diagnostic pitfall.

Rosa M, Mohammadi A, Masood S.

Pathol Res Pract. 2010 Aug 15;206(8):544-9. doi: 10.1016/j.prp.2010.02.010.

PMID:
20359832
19.

Invasive lobular carcinoma: to grade or not to grade.

Bane AL, Tjan S, Parkes RK, Andrulis I, O'Malley FP.

Mod Pathol. 2005 May;18(5):621-8.

20.

Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization.

Jacobs TW, Pliss N, Kouria G, Schnitt SJ.

Am J Surg Pathol. 2001 Feb;25(2):229-36.

PMID:
11176072
Items per page

Supplemental Content

Support Center